143 related articles for article (PubMed ID: 25909793)
1. [No effect of the BDNF Val66Met polymorphism on cognitive deficit in patients with schizophrenia and on the risk of the disease in their relatives].
Alfimova MV; Golimbet VE; Korovaitseva GI; Lezheiko TV; Gabaeva MV; Oleichik IV; Stolyarov SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):75-79. PubMed ID: 25909793
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
3. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
6. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
[TBL] [Abstract][Full Text] [Related]
7. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
[TBL] [Abstract][Full Text] [Related]
8. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
[TBL] [Abstract][Full Text] [Related]
9. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
[TBL] [Abstract][Full Text] [Related]
10. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.
Naoe Y; Shinkai T; Hori H; Fukunaka Y; Utsunomiya K; Sakata S; Matsumoto C; Shimizu K; Hwang R; Ohmori O; Nakamura J
Neurosci Lett; 2007 Mar; 415(2):108-12. PubMed ID: 17267117
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.
Gratacòs M; González JR; Mercader JM; de Cid R; Urretavizcaya M; Estivill X
Biol Psychiatry; 2007 Apr; 61(7):911-22. PubMed ID: 17217930
[TBL] [Abstract][Full Text] [Related]
13. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients.
Hong CJ; Yu YW; Lin CH; Tsai SJ
Neurosci Lett; 2003 Oct; 349(3):206-8. PubMed ID: 12951204
[TBL] [Abstract][Full Text] [Related]
14. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
[TBL] [Abstract][Full Text] [Related]
15. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
[TBL] [Abstract][Full Text] [Related]
16. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
[TBL] [Abstract][Full Text] [Related]
18. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
Suchanek R; Owczarek A; Paul-Samojedny M; Kowalczyk M; Kucia K; Kowalski J
J Neuropsychiatry Clin Neurosci; 2013; 25(1):88-94. PubMed ID: 23487199
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.
Szabo AJ; Alosco ML; Miller LA; McGeary JE; Poppas A; Cohen RA; Gunstad J
Psychogeriatrics; 2013 Dec; 13(4):206-12. PubMed ID: 24289461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
